Latvia vs Norway: Proportion of isolates with decreased susceptibility or resistance
Latvia
0
in 2018
Norway
0
in 2018
Latvia rank
15th
Norway rank
15th
Proportion of isolates with decreased susceptibility or resistance over time
- Latvia
- Norway
How they compare
Latvia currently reports 0 against 0 in Norway, a difference of 0.
Across all 10 years both countries report, Norway has been ahead every year.
Latvia ranks 15th and Norway ranks 15th of 27 countries.
Norway has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Latvia | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 | 0.9091 | 0.9091 | Norway |
| 2010s | 0.5773 | 2.98 | 2.4 | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Latvia or Norway?
- Latvia, at 0 against 0 in Norway as of 2018.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Latvia and Norway?
- 0, with Latvia ahead.
- How many years of comparable data are there for Latvia and Norway?
- 10 years are reported by both, from 2009 to 2018.
- How do Latvia and Norway rank globally for proportion of isolates with decreased susceptibility or resistance?
- Latvia ranks 15th and Norway ranks 15th of 27 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.